D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Morningstar
MORN
$7.38B
| $2.06M | ﹤0.01% |
9,137
-8,903
| -49% | -$2.09M |
|
2427
CALL
RB Global
RBA
$21.7B
| $2.06M | ﹤0.01% |
35,100
+16,000
| +84% | +$938K |
|
|
DHBCU
2428
DELISTED
DHB Capital Corp. Unit
DHBCU
| $2.05M | ﹤0.01% |
+206,785
| New | +$2.06M |
|
2429
CALL
Wingstop
WING
$3.67B
| $2.04M | ﹤0.01% |
16,000
-10,100
| -39% | -$1.42M |
|
2430
CALL
Floor & Decor
FND
$6.14B
| $2.03M | ﹤0.01% |
21,300
| – | – |
|
2431
Enanta Pharmaceuticals
ENTA
$367M
| $2.03M | ﹤0.01% |
41,184
+18,975
| +85% | +$946K |
|
|
CVIIU
2432
DELISTED
Churchill Capital Corp VII Units
CVIIU
| $2.03M | ﹤0.01% |
+203,639
| New | +$2.1M |
|
2433
CALL
Dollar General
DG
$27.8B
| $2.03M | ﹤0.01% |
10,000
-19,100
| -66% | -$3.79M |
|
|
2434
PUT
Dollar General
DG
$27.8B
| $2.03M | ﹤0.01% |
+10,000
| New | +$1.99M |
|
|
DGNU
2435
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
| $2.02M | ﹤0.01% |
+200,000
| New | +$2.02M |
|
2436
AAR Corp
AIR
$5.62B
| $2.02M | ﹤0.01% |
48,483
+20,567
| +74% | +$812K |
|
|
RXRAU
2437
DELISTED
RXR Acquisition Corp. Units
RXRAU
| $2.02M | ﹤0.01% |
+205,000
| New | +$2.04M |
|
|
SIX
2438
PUT
DELISTED
Six Flags Entertainment Corp.
SIX
| $2.02M | ﹤0.01% |
+43,400
| New | +$1.81M |
|
|
HTBK
2439
DELISTED
Heritage Commerce
HTBK
| $2.02M | ﹤0.01% |
164,890
-56,968
| -26% | -$570K |
|
|
HA
2440
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.01M | ﹤0.01% |
75,526
-3,340
| -4% | -$79.2K |
|
2441
Cable One
CABO
$249M
| $2.01M | ﹤0.01% |
1,101
-214
| -16% | -$418K |
|
2442
CALL
Viatris
VTRS
$20.8B
| $2.01M | ﹤0.01% |
144,000
-75,300
| -34% | -$1.23M |
|
2443
Lesaka Technologies
LSAK
$392M
| $2.01M | ﹤0.01% |
358,545
-153,013
| -30% | -$799K |
|
2444
Phibro Animal Health
PAHC
$1.48B
| $2.01M | ﹤0.01% |
82,296
-21,709
| -21% | -$490K |
|
|
ABMD
2445
PUT
DELISTED
Abiomed Inc
ABMD
| $2.01M | ﹤0.01% |
6,300
-82,800
| -93% | -$26.5M |
|
2446
Leidos
LDOS
$14.9B
| $2M | ﹤0.01% |
20,819
-155,324
| -88% | -$15.7M |
|
2447
Flotek Industries
FTK
$856M
| $2M | ﹤0.01% |
198,429
-6,546
| -3% | -$81.4K |
|
2448
Equinor
EQNR
$90.9B
| $2M | ﹤0.01% |
+102,715
| New | +$1.95M |
|
2449
PUT
PG&E
PCG
$39.2B
| $2M | ﹤0.01% |
170,600
-299,400
| -64% | -$3.48M |
|
|
RDFN
2450
PUT
DELISTED
Redfin
RDFN
| $2M | ﹤0.01% |
+30,000
| New | +$2.29M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.